Welcome Guest!  Login | Register | Help | Survey
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
CVD [NYSE]
Covance Inc.
Healthcare - Medical Laboratories & Research - USA
Index- P/E20.12 EPS (ttm)2.74 Insider Own0.67% Shs Outstand64.03M Perf Week-3.45%
Market Cap3.53B Forward P/E16.81 EPS next Y3.28 Insider Trans-12.27% Shs Float63.60M Perf Month0.97%
Income175.88M PEG1.33 EPS next Q0.60 Inst Own95.00% Short Float11.16% Perf Quarter2.82%
Sales1.96B P/S1.80 EPS this Y-11.11% Inst Trans1.03% Short Ratio9.80 Perf Half Y-0.31%
Book/sh22.03 P/B2.50 EPS next Y22.85% ROA9.39% Target Price60.04 Perf Year34.66%
Cash/sh4.52 P/C12.19 EPS next 5Y15.14% ROE13.50% 52W Range32.31 - 61.59 Perf YTD1.03%
Dividend- P/FCF27.58 EPS past 5Y12.53% ROI12.21% 52W High-10.49% Beta1.05
Dividend %- Quick Ratio1.98 Sales past 5Y13.19% Gross Margin30.15% 52W Low70.63% ATR1.74
Employees10000 Current Ratio2.18 Sales Q/Q9.38% Oper. Margin11.67% RSI (14)46.97 Volatility3.51% 3.36%
OptionableYes Debt/Eq0.00 EPS Q/Q-10.33% Profit Margin8.93% Rel Volume1.29 Prev Close55.43
ShortableYes LT Debt/Eq0.00 EarningsJan 27 AMC Payout- Avg Volume723.98K Price55.13
Recom2.20 SMA20-3.53% SMA500.88% SMA2007.77% Volume934,187 Change-0.54%
22-Sep-09Upgrade Jefferies & Co Hold → Buy $56 → $65
16-Jul-09Initiated JP Morgan Overweight
21-May-09Initiated Leerink Swann Mkt Perform
13-May-09Initiated Deutsche Securities Buy
05-Feb-09Reiterated Jefferies & Co Hold $38 → $42
26-Jan-09Reiterated Jefferies & Co Hold $40 → $38
23-Dec-08Initiated Piper Jaffray Buy
19-Dec-08Reiterated UBS Neutral $38 → $46
19-Dec-08Reiterated Jefferies & Co Hold $44 → $40
18-Dec-08Downgrade Ladenburg Thalmann Buy → Neutral
20-Nov-08Reiterated UBS Neutral $61 → $38
17-Nov-08Initiated Edward Jones Buy
23-Oct-08Downgrade Jefferies & Co Buy → Hold $108 → $67
02-Oct-08Upgrade Ladenburg Thalmann Neutral → Buy
20-Aug-08Initiated UBS Neutral $104
06-Aug-08Reiterated Ladenburg Thalmann Neutral $93 → $99
01-Aug-08Reiterated Lehman Brothers Overweight $95 → $96
31-Jul-08Reiterated Ladenburg Thalmann Neutral $89 → $93
02-Jul-08Initiated Ladenburg Thalmann Neutral $89
04-Feb-08Upgrade UBS Neutral → Buy
08-Feb-10 06:00PM  UPDATE - PPD Q4 profit edges past estimates at Reuters
07:00AM  Covance To Present At The 20th Annual Global Healthcare Services Conference PR Newswire
03-Feb-10 02:20PM  The Biggest Challenges Facing Biotechs at Minyanville.com
02-Feb-10 05:05PM  Nektar adds to board of directors at bizjournals.com
31-Jan-10 10:11AM  China Biotech in Review: More Money Raised in China IPOs in 2009 than in the U.S. at Seeking Alpha
10:06AM  Covance Increases Emerging Markets Focus: Building Pre-Clinical Facility in China at Seeking Alpha
29-Jan-10 12:17AM  Covance Inc. Q4 2009 Earnings Call Transcript at Seeking Alpha
28-Jan-10 09:24AM  New Star Analyst Rankings for COVANCE INC StarMine
07:00AM  Covance Inc. Invites You to Join the Webcast of Its Fourth Quarter 2009 Financial Results Conference Call PR Newswire
27-Jan-10 08:57PM  Lightning Round OT: EMC, PPL and More at CNBC
04:58PM  COVANCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:58PM  UPDATE - Covance Q4 earnings, 2010 profit view below market at Reuters
04:15PM  InPlay: Covance misses by $0.01, beats on revs; guides Q1 EPS below consensus; guides FY10 EPS below consensus, revs below consensus Briefing.com
04:10PM  Covance Reports Fourth Quarter Revenue of $485M and EPS of $0.64 Per Share PR Newswire
07:07AM  Q4 2009 Covance Earnings Release - After Market Close CCBN
25-Jan-10 03:53PM  Bradley Sheares elected to Henry Schein board AP
08:54AM  Growth In Personalized Medicine Means Growth In Diagnostics Companies: Key To Early Detection Of Life Threatening Illnesses Is Through These Stocks Wall Street Transcript
21-Jan-10 05:31AM  Zacks #5 Rank Additions for Thursday Zacks.com
11-Jan-10 04:58PM  Covance Inc. Invites You to Join the Webcast of Its Fourth Quarter 2009 Financial Results Conference Call PR Newswire
02:42PM  Analyst cautious on drug research outsourcing AP
10:43AM  Covance to Present at the 28th Annual J.P. Morgan Healthcare Conference PR Newswire
31-Dec-09 06:54PM  Contract Researchers, PBMs Eye Strong 2010 Investor's Business Daily
22-Dec-09 04:12PM  COVANCE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Officers EDGAR Online
16-Dec-09 05:00AM  Biotech Built for Life: Under the Radar at TheStreet.com
15-Dec-09 09:00AM  Covance Opens New Clinical Development Offices in South Korea and India; Expands Offices in Japan and Hong Kong PR Newswire
14-Dec-09 11:06AM  Roughly $280 Billion In Medicaid Spending Directed To The Elderly And Handicapped: Huge Market Opportunity Exists For Select Stocks Wall Street Transcript
10-Dec-09 11:30AM  Former Blue Shield Director Gives His Picks In the PBM And Health Insurance Space Wall Street Transcript
02-Dec-09 02:54PM  5-Star Stocks on the Upswing at Motley Fool
01-Dec-09 09:48AM  Covance to Establish a New Nutritional Chemistry and Food Safety Laboratory in Battle Creek, Michigan PR Newswire
30-Nov-09 01:11PM  Covance to Present at Piper Jaffray 21st Annual Health Care Conference PR Newswire
25-Nov-09 07:00AM  We Expect Ailing CROs to Recover Morningstar.com
22-Nov-09 08:03AM  China Biotech Week in Review: CROs Consolidating at Seeking Alpha
20-Nov-09 03:03PM  The Stockpickers: Fund managers hunt small-caps that can grow bigger at MarketWatch
04:38AM  Zacks #5 Rank Additions for Friday Zacks.com
18-Nov-09 09:17AM  Rules-Based Medicine Forms Biomarker Alliance With Covance Inc. PR Newswire
09:15AM  Covance Enters Into a Biomarker Alliance With Rules-Based Medicine, Inc. PR Newswire
12-Nov-09 04:25PM  How Do You Say 'Drug Development' in Mandarin? at Motley Fool
10-Nov-09 08:00AM  Covance To Present at Credit Suisse Healthcare Conference PR Newswire
06-Nov-09 09:04AM  COVANCE INC Financials EDGAR Online Financials
03-Nov-09 05:14PM  UPDATE - Charles River posts lower Q3 profit, cuts 2009 EPS view at Reuters
04:43PM  Charles River Q3 Misses, Forecast Light at Barrons.com
02-Nov-09 04:01PM  CFO Interview: BioPharm Asia, Inc. - Michael Guo Wall Street Transcript
10:09AM  COVANCE INC Files SEC form 10-Q, Quarterly Report EDGAR Online
29-Oct-09 03:28PM  Pharma Researchers Need a Cure at Motley Fool
28-Oct-09 08:09AM  Marcial: Why Pros Covet Covance at BusinessWeek
27-Oct-09 06:00PM  UPDATE - PPD Q3 EPS meets Street, cuts '09 view on poor bookings at Reuters
05:12PM  UPDATE - Parexel posts lower Q1 profit, sees Q2 below estimates at Reuters
26-Oct-09 04:01PM  Covance Receives AAALAC Accreditation for Early Development Facility in Chandler PR Newswire
23-Oct-09 03:58PM  Taking the Drug Industry's Temperature at Motley Fool
22-Oct-09 03:19PM  Covance Inc. Q3 2009 Earnings Call Transcript at Seeking Alpha
06:00AM  Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2009 Financial Results Conference Call PR Newswire
21-Oct-09 05:42PM  Earnings roundup: Wells Fargo, eBay AP
05:28PM  UPDATE - Covance Q3 profit meets market view, sees weak Q4 at Reuters
05:27PM  Covance 3Q profit remains flat AP
05:24PM  COVANCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:03PM  Covance Reports Third Quarter Revenue of $475M and EPS of $0.67 Per Share PR Newswire
07:07AM  Q3 2009 Covance Earnings Release - After Market Close CCBN
09-Oct-09 04:21PM  /C O R R E C T I O N -- Covance Inc./ PR Newswire
06-Oct-09 09:50AM  5-Star Stocks Poised to Pop: inVentiv Health at Motley Fool
05-Oct-09 10:29AM  Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2009 Financial Results Conference Call PR Newswire
24-Sep-09 06:50AM  StockPreacher.com Issues Technical Trading Overview for WuXi PharmaTech (Cayman) Inc. GlobeNewswire
22-Sep-09 09:30AM  Premarket roundup: Corp. Executive Board, Covance AP
07:41AM  Ahead of the Bell: Covance upgraded after slide AP
04:44AM  Covance upgraded by Jefferies & Co Briefing.com
18-Sep-09 12:24PM  Covance to Present at UBS Global Life Sciences Conference PR Newswire
17-Sep-09 03:32AM  Pundits Are Wrong: Healthcare Reform Will Increase Profits at Seeking Alpha
16-Sep-09 08:23PM  Lightning Round OT: Kinder Morgan Energy, Loews and More at CNBC
09-Sep-09 12:11PM  Covance Opens New Clinical Development Offices in Brazil and Mexico PR Newswire
06:00AM  Covance to Present at Thomas Weisel Partners 2009 Healthcare Conference PR Newswire
03-Sep-09 01:55PM  China's drug contractors on a fast-growth track at Reuters
01-Sep-09 12:01AM  The Technical Indicator: A defensive approach to a seasonally weak month at MarketWatch
31-Aug-09 11:52AM  Phase Forward Completes Acquisition Zacks.com
20-Aug-09 02:19PM  Phase Forward buys Covance business AP
18-Aug-09 05:22PM  Covance signs contract, deal with Merck AP
04:01PM  Covance and Merck & Co., Inc. Finalize Strategic Agreement PR Newswire
14-Aug-09 01:15PM  Remedy for a malady at FT.com
13-Aug-09 02:40PM  WuXi: Making Money Both Ways at Motley Fool
12:10PM  Today's 5-Star Movers at Motley Fool
09-Aug-09 02:44AM  Spotlight on Biotech: 10 Promising Companies at Seeking Alpha
04-Aug-09 04:04PM  COVANCE INC Files SEC form 10-Q, Quarterly Report EDGAR Online
30-Jul-09 04:09PM  Covance Advances at Motley Fool +8.02%
03:13PM  Covance Inc. Q2 2009 Earnings Call Transcript at Seeking Alpha
07:05AM  Covance acquiring Mercks Gene Expression Lab in Seattle at bizjournals.com
07:00AM  Covance Inc. Invites You to Join the Webcast of Its Second Quarter 2009 Financial Results Conference Call PR Newswire
29-Jul-09 07:03PM  Covance 2Q profit, sales beat expectations AP
05:42PM  UPDATE - Covance beats profit, revenue forecasts at Reuters
04:49PM  COVANCE INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:14PM  Covance Reports Second Quarter Revenue of $466M and EPS of $0.66 PR Newswire
04:02PM  Covance to Acquire Seattle-Based Gene Expression Laboratory from Merck & Co., Inc. PR Newswire
07:07AM  Q2 2009 Covance Earnings Release - After Market Close CCBN
24-Jul-09 12:03PM  Today's 5-Star Movers at Motley Fool
22-Jul-09 04:03PM  Canaries in the Drug Coal Mine at Motley Fool -8.10%
15-Jul-09 03:52PM  Phase Forward buys voice, Web business for $10M AP
09:46AM  Covance to Sell Its Interactive Voice and Web Response Services and Enter Into a Multi-Year Marketing Agreement with Phase Forward PR Newswire
09-Jul-09 06:58AM  TheFortuneFinancial.com Free Market Research on IBM, ABB, HTZ, MAC, CVD and MCK Marketwire
06-Jul-09 03:06PM  Covance Inc. Invites You to Join the Webcast of Its Second Quarter 2009 Financial Results Conference Call PR Newswire
01-Jul-09 05:27PM  [video] The Obama Trade: Healthcare at CNBC
22-Jun-09 04:45PM  COVANCE INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits EDGAR Online
07:00AM  Is It Time to Test Contract Research Organizations? Morningstar.com
19-Jun-09 05:39PM  5 Overbought Stocks For Traders To Watch at Investopedia
Covance Inc., a drug development services company, provides early-stage and late-stage product development services primarily to the pharmaceutical, biotechnology, and medical device industries worldwide. Its early stage development services include preclinical services, such as toxicology, pharmaceutical and nutritional chemistry, polyclonal and monoclonal antibody services, and bioanalytical services; and clinical pharmacology services, including first-in-human trials of new pharmaceuticals. The company's late stage development services include central laboratory services, including biomarker services to biotechnology and pharmaceutical customers; clinical development services comprising the full management of Phase II and III clinical studies, study design and modeling, study orchestration, trial logistics, enablement of study site performance, clinical data management and biostatistical analysis, and medical writing and regulatory services; clinical trial support services that include cardiac safety services; and commercialization services, such as periapproval services and market access services. It also offers laboratory testing services to the chemical, agrochemical, and food industries. The company was founded in 1987 and is based in Princeton, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LOVETT JAMES WCorporate Sr. Vice PresidentFeb 04Option Exercise25.135,550139,48437,895Feb 05 04:49 PM
LOVETT JAMES WCorporate Sr. Vice PresidentFeb 04Sale54.385,550301,80332,345Feb 05 04:49 PM
Cimino Richard FCorporate Sr. Vice PresidentNov 03Option Exercise29.698,794261,09452,242Nov 05 04:14 PM
Cimino Richard FCorporate Sr. Vice PresidentNov 03Sale52.6313,866729,81738,376Nov 05 04:14 PM
KLITGAARD WILLIAM ECorporate Sr. Vice PresidentOct 26Option Exercise18.8317,700333,35172,746Oct 27 04:17 PM
KLITGAARD WILLIAM ECorporate Sr. Vice PresidentOct 26Sale55.0435,7001,964,99637,046Oct 27 04:17 PM
LOVETT JAMES WCorporate Sr. Vice PresidentSep 21Sale57.705,000288,50034,416Sep 23 04:26 PM
BARR WENDELExecutive Vice President & COOJun 03Sale45.2219,945901,91345,160Jun 05 04:20 PM
HELTON SANDRA LDirectorMay 20Option Exercise0.001,20003,600May 21 12:54 PM
BARCHI ROBERTDirectorMay 20Option Exercise0.001,20002,400May 21 12:53 PM
Bang Kathleen GDirectorMay 20Option Exercise0.001,20003,200May 21 12:51 PM
KLITGAARD WILLIAM ECorporate Sr. Vice PresidentFeb 03Option Exercise27.4410,000274,40047,409Feb 04 04:18 PM